Financhill
Back

Pliant Therapeutics Stock Price Chart

  • Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and PLRX is experiencing buying pressure, which is a positive indicator for future bullish movement.

Pliant Therapeutics Price Chart Indicators

Moving Averages Level Buy or Sell
8-day SMA: 13.16 Sell
20-day SMA: 14.05 Sell
50-day SMA: 13.02 Sell
200-day SMA: 13.4 Sell
8-day EMA: 13.14 Sell
20-day EMA: 13.59 Sell
50-day EMA: 13.37 Sell
200-day EMA: 13.78 Sell

Pliant Therapeutics Technical Analysis Indicators

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.18 Sell
Relative Strength Index (14 RSI): 41.48 Sell
Chaikin Money Flow: 461837 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (13.28 - 15.1) Sell
Bollinger Bands (100): (11.61 - 14.11) Sell

Pliant Therapeutics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Technical Analysis for Pliant Therapeutics Stock

Is Pliant Therapeutics Stock a Buy?

PLRX Technical Analysis vs Fundamental Analysis

Sell
39
Pliant Therapeutics (PLRX) is a Sell

Is Pliant Therapeutics a Buy or a Sell?

Pliant Therapeutics Stock Info

Market Cap:
774.67M
Price in USD:
12.73
Share Volume:
480.31K

Pliant Therapeutics 52-Week Range

52-Week High:
19.62
52-Week Low:
10.22
Sell
39
Pliant Therapeutics (PLRX) is a Sell

Pliant Therapeutics Share Price Forecast

Is Pliant Therapeutics Stock a Buy?

  • Pliant Therapeutics share price is 12.73 while PLRX 8-day exponential moving average is 13.14, which is a Sell signal.
  • The stock price of PLRX is 12.73 while Pliant Therapeutics 20-day EMA is 13.59, which makes it a Sell.
  • Pliant Therapeutics 50-day exponential moving average is 13.37 while PLRX share price is 12.73, making it a Sell technically.
  • PLRX stock price is 12.73 and Pliant Therapeutics 200-day simple moving average is 13.78, creating a Sell signal.

Fundamental Analysis of Pliant Therapeutics

Is Pliant Therapeutics a good investment?

  • Analysts estimate an earnings decrease this quarter of $0.06 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.74 per share, and a decrease next year of $0.33 per share.

Technical Analysis of Pliant Therapeutics

Should I short Pliant Therapeutics stock?

* Pliant Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.